BST2/Tetherin inhibits hepatitis C virus production in human hepatoma cells

Antiviral Research

Volumn 98, Issue 1, 2013, Pages 54-60

  Pan, Xiao Ben ^a   Qu, Xiao Wang ^b   Jiang, Dong ^a   Zhao, Xing Liang ^a   Han, Jin Chao ^a   Wei, Lai ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

BST2; HCV; Interferon

Indexed keywords

ALPHA INTERFERON; CD137 ANTIGEN; CORE PROTEIN; MEMBRANE PROTEIN; PROTEIN BST2; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; GENOME ANALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LIVER CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRION; VIRUS REPLICATION; WESTERN BLOTTING;

ANTIGENS, CD; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; GPI-LINKED PROTEINS; HEPACIVIRUS; HUMANS; LIVER NEOPLASMS; PROTEIN TRANSPORT; VIRAL PROTEINS; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 84874934919     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2013.01.009     Document Type: Article

References (35)

1. Bartosch B., Dubuisson J., Cosset F.L. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J. Exp. Med. 2003, 197:633-642.
2. Blight K.J., McKeating J.A., Rice C.M. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J. Virol. 2002, 76:13001-13014.
3. Broering R., Zhang X., Kottilil S., Trippler M., Jiang M., Lu M., Gerken G., Schlaak J.F. The interferon stimulated gene 15 functions as a proviral factor for the hepatitis C virus and as a regulator of the IFN response. Gut 2010, 59:1111-1119.
4. Chang K.S., Cai Z., Zhang C., Sen G.C., Williams B.R., Luo G. Replication of hepatitis C virus (HCV) RNA in mouse embryonic fibroblasts: protein kinase R (PKR)-dependent and PKR-independent mechanisms for controlling HCV RNA replication and mediating interferon activities. J. Virol. 2006, 80:7364-7374.
5. Chua P.K., McCown M.F., Rajyaguru S., Kular S., Varma R., Symons J., Chiu S.S., Cammack N., Najera I. Modulation of alpha interferon anti-hepatitis C virus activity by ISG15. J. Gen. Virol. 2009, 90:2929-2939.
6. Dafa-Berger A., Kuzmina A., Fassler M., Yitzhak-Asraf H., Shemer-Avni Y., Taube R. Modulation of hepatitis C virus release by the interferon-induced protein BST-2/tetherin. Virology 2012, 428:98-111.
7. Dube M., Roy B.B., Guiot-Guillain P., Mercier J., Binette J., Leung G., Cohen E.A. Suppression of tetherin-restricting activity upon human immunodeficiency virus type 1 particle release correlates with localization of Vpu in the trans-Golgi network. J. Virol. 2009, 83:4574-4590.
8. Gastaminza P., Cheng G., Wieland S., Zhong J., Liao W., Chisari F.V. Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion. J. Virol. 2008, 82:2120-2129.
9. Guo J.T., Bichko V.V., Seeger C. Effect of alpha interferon on the hepatitis C virus replicon. J. Virol. 2001, 75:8516-8523.
10. Hayashi J., Stoyanova R., Seeger C. The transcriptome of HCV replicon expressing cell lines in the presence of alpha interferon. Virology 2005, 335:264-275.
11. Helbig K.J., Lau D.T., Semendric L., Harley H.A., Beard M.R. Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector. Hepatology 2005, 42:702-710.
12. Itsui Y., Sakamoto N., Kakinuma S., Nakagawa M., Sekine-Osajima Y., Tasaka-Fujita M., Nishimura-Sakurai Y., Suda G., Karakama Y., Mishima K., Yamamoto M., Watanabe T., Ueyama M., Funaoka Y., Azuma S., Watanabe M. Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein. Hepatology 2009, 50:1727-1737.
13. Jiang D., Guo H., Xu C., Chang J., Gu B., Wang L., Block T.M., Guo J.T. Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus. J. Virol. 2008, 82:1665-1678.
14. Jiang D., Weidner J.M., Qing M., Pan X.B., Guo H., Xu C., Zhang X., Birk A., Chang J., Shi P.Y., Block T.M., Guo J.T. Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections. J. Virol. 2010, 84:8332-8341.
15. Jones D.M., McLauchlan J. Hepatitis C virus: assembly and release of virus particles. J. Biol. Chem. 2010, 285:22733-22739.
16. Jouvenet N., Neil S.J., Zhadina M., Zang T., Kratovac Z., Lee Y., McNatt M., Hatziioannou T., Bieniasz P.D. Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin. J. Virol. 2009, 834:1837-1844.
17. Kim J.H., Luo J.K., Zhang D.E. The level of hepatitis B virus replication is not affected by protein ISG15 modification but is reduced by inhibition of UBP43 (USP18) expression. J. Immunol. 2008, 181:6467-6672.
18. Kong W.S., Irie T., Yoshida A., Kawabata R., Kadoi T., Sakaguchi T. Inhibition of virus-like particle release of Sendai virus and Nipah virus, but not that of mumps virus, by tetherin/CD317/BST-2. Hiroshima J. Med. Sci. 2012, 61:59-67.
19. Kupzig S., Korolchuk V., Rollason R., Sugden A., Wilde A., Banting G. Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology. Traffic 2003, 694-709.
20. Lindenbach B.D., Evans M.J., Syder A.J., Wolk B., Tellinghuisen T.L., Liu C.C., Maruyama T., Hynes R.O., Burton D.R., McKeating J.A., Rice C.M. Complete replication of hepatitis C virus in cell culture. Science 2005, 309:623-626.
21. Lindenbach B.D., Rice C.M. Unravelling hepatitis C virus replication from genome to function. Nature 2005, 436:933-938.
22. Marcello T., Grakoui A., Barba-Spaeth G., Machlin E.S., Kotenko S.V., MacDonald M.R., Rice C.M. Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. Gastroenterology 2006, 131:1887-1898.
23. Metz P., Dazert E., Ruggieri A., Mazur J., Kaderali L., Kaul A., Zeuge U., Windisch M.P., Trippler M., Lohmann V., Binder M., Frese M., Bartenschlager R. Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication. Hepatology 2012, 56:2082-2093.
24. Miyanari Y., Atsuzawa K., Usuda N., Watashi K., Hishiki T., Zayas M., Bartenschlager R., Wakita T., Hijikata M., Shimotohno K. The lipid droplet is an important organelle for hepatitis C virus production. Nat. Cell Biol. 2007, 9:1089-1097.
25. Neil S.J., Zang T., Bieniasz P.D. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008, 451:425-430.
26. Pietschmann T., Kaul A., Koutsoudakis G., Shavinskaya A., Kallis S., Steinmann E., Abid K., Negro F., Dreux M., Cosset F.L., Bartenschlager R. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc. Natl. Acad. Sci. USA 2006, 103:7408-7413.
27. Qu X., Pan X., Weidner J., Yu W., Alonzi D., Xu X., Butters T., Block T., Guo J.T., Chang J. Inhibitors of endoplasmic reticulum alpha-glucosidases potently suppress hepatitis C virus virion assembly and release. Antimicrob. Agents Chemother. 2011, 55:1036-1044.
28. Sakuma T., Noda T., Urata S., Kawaoka Y., Yasuda J. Inhibition of Lassa and Marburg virus production by tetherin. J. Virol. 2009, 83:2382-2385.
29. Schubert H.L., Zhai Q., Sandrin V., Eckert D.M., Garcia-Maya M., Saul L., Sundquist W.I., Steiner R.A., Hill C.P. Structural and functional studies on the extracellular domain of BST2/tetherin in reduced and oxidized conformations. Proc. Natl. Acad. Sci. USA 2010, 107:17951-17956.
30. Swiecki M., Scheaffer S.M., Allaire M., Fremont D.H., Colonna M., Brett T.J. Structural and biophysical analysis of BST-2/tetherin ectodomains reveal an evolutionary conserved design to inhibit virus release. J. Biol. Chem. 2011, 286:2987-2997.
31. Taylor D.R., Puig M., Darnell M.E., Mihalik K., Feinstone S.M. New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1. J. Virol. 2005, 79:6291-6298.
32. Weidner J.M., Jiang D., Pan X.B., Chang J., Block T.M., Guo J.T. Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms. J. Virol. 2010, 84:12646-12657.
33. Yang H., Wang J., Jia X., McNatt M.W., Zang T., Pan B., Meng W., Wang H.W., Bieniasz P.D., Xiong Y. Structural insight into the mechanisms of enveloped virus tethering by tetherin. Proc. Natl. Acad. Sci. USA 2010, 107:18428-18432.
34. Ye L., Wang X., Li J., Liu J., Ramirez S.H., Wu J., Ho W. Tetherin has negligible activity in restricting hepatitis C virus in hepatocytes. Innate Immun. 2012, 18:398-405.
35. Zhou Z., Wang N., Woodson S.E., Dong Q., Wang J., Liang Y., Rijnbrand R., Wei L., Nichols J.E., Guo J.T., Holbrook M.R., Lemon S.M., Li K. Antiviral activities of ISG20 in positive-strand RNA virus infections. Virology 2011, 409:175-188.